CAPRICOR THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (CAPR) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2019 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
CAPR on Nasdaq
Shares outstanding
51,513,636
Price per share
$24.79
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
14,454,900
Total reported value
$104,097,739
% of total 13F portfolios
0%
Share change
+723,225
Value change
+$3,051,768
Number of holders
114
Price from insider filings
$24.79
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CAPRICOR THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (CAPR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TANG CAPITAL MANAGEMENT LLC 6.6% $98,136,074 3,399,900 TANG CAPITAL MANAGEMENT, LLC 16 Jan 2026
BlackRock, Inc. 6.5% $27,562,631 2,966,914 BlackRock, Inc. 31 Dec 2024
VANGUARD GROUP INC 4.8% -4.4% $15,910,444 -$709,168 2,206,719 -4.3% The Vanguard Group 30 Sep 2025

As of 30 Sep 2025, 114 institutional investors reported holding 14,454,900 shares of CAPRICOR THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (CAPR). This represents 28% of the company’s total 51,513,636 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of CAPRICOR THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (CAPR) together control 24% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 5.6% 2,870,172 -3.8% 0% $20,693,940
VANGUARD GROUP INC 4.3% 2,206,719 -4.3% 0% $15,910,444
GEODE CAPITAL MANAGEMENT, LLC 1.9% 961,566 -0.16% 0% $6,934,347
STATE STREET CORP 1.6% 801,344 -45% 0% $5,777,690
MORGAN STANLEY 1.1% 551,694 +0.2% 0% $3,977,714
Pier Capital, LLC 0.96% 496,554 +35% 0.56% $3,580,154
J. Goldman & Co LP 0.94% 481,981 0.13% $3,475,083
DG Capital Management, LLC 0.91% 470,333 2% $3,391,101
NATIONAL BANK OF CANADA /FI/ 0.77% 397,700 +136% 0% $2,867,417
TWO SIGMA INVESTMENTS, LP 0.69% 355,796 +128% 0% $2,565,289
NORTHERN TRUST CORP 0.68% 352,521 -4.9% 0% $2,541,677
Black Diamond Financial, LLC 0.54% 277,737 0% 0.22% $2,002,484
Ikarian Capital, LLC 0.51% 264,642 0.43% $1,908,069
GSA CAPITAL PARTNERS LLP 0.42% 215,675 0.13% $1,555,000
MILLENNIUM MANAGEMENT LLC 0.39% 202,459 +16% 0% $1,459,729
RAYMOND JAMES FINANCIAL INC 0.37% 191,292 +1630% 0% $1,379,216
JPMORGAN CHASE & CO 0.37% 189,799 -2.8% 0% $1,368,451
GOLDMAN SACHS GROUP INC 0.34% 175,642 +144% 0% $1,266,379
HBK Sorce Advisory LLC 0.33% 170,577 +34% 0.03% $1,141,160
CITADEL ADVISORS LLC 0.29% 150,522 0% $1,085,263
OPPENHEIMER & CO INC 0.26% 135,413 -17% 0.01% $976,328
WELLINGTON MANAGEMENT GROUP LLP 0.26% 132,315 +0.33% 0% $953,992
Quinn Opportunity Partners LLC 0.25% 128,338 0.07% $925,317
UBS Group AG 0.24% 124,717 -77% 0% $899,210
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.23% 120,285 0% 0% $867,255

Institutional Holders of CAPRICOR THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (CAPR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 3,207,148 $92,558,644 +$6,893,366 $28.86 22
2025 Q3 14,454,900 $104,097,739 +$3,051,768 $7.21 114
2025 Q2 13,740,752 $136,510,446 -$45,087,127 $9.93 105
2025 Q1 18,332,527 $174,017,963 +$4,472,874 $9.49 120
2024 Q4 17,323,700 $239,076,137 +$122,907,749 $13.80 107
2024 Q3 8,369,327 $127,297,254 +$33,783,760 $15.21 79
2024 Q2 6,426,234 $30,652,544 +$6,579,061 $4.77 62
2024 Q1 4,817,759 $32,711,658 +$5,040,709 $6.79 55
2023 Q4 52,800 $258,192 +$258,192 $4.89 1
2023 Q3 5,534,651 $18,927,822 +$9,929,580 $3.42 33
2023 Q2 2,622,432 $12,534,719 +$927,959 $4.78 31
2023 Q1 2,431,814 $10,261,609 -$1,225,034 $4.22 29
2022 Q4 2,737,085 $10,561,951 -$271,549 $3.86 30
2022 Q3 2,790,441 $16,740,600 +$1,629,859 $6.00 27
2022 Q2 2,538,209 $8,854,000 -$139,331 $3.49 26
2022 Q1 2,583,380 $8,860,000 +$963,587 $3.43 25
2021 Q4 2,281,506 $6,685,000 -$685,993 $2.93 21
2021 Q3 2,486,005 $10,007,000 -$5,543,635 $4.02 26
2021 Q2 3,523,266 $18,071,000 -$4,151,855 $5.13 26
2021 Q1 4,351,350 $20,362,000 +$13,469,610 $4.68 27
2020 Q4 1,485,358 $5,093,000 +$723,325 $3.43 22
2020 Q3 1,244,147 $6,533,000 +$1,916,753 $5.25 21
2020 Q2 926,617 $4,262,000 +$2,921,667 $4.60 28
2020 Q1 496,335 $594,000 +$333,256 $1.20 12
2019 Q4 214,939 $275,000 +$78,221 $1.29 11
2019 Q3 123,168 $457,000 +$151,132 $3.72 14
2019 Q2 84,706 $281,000 +$280,999 $3.33 10